Plains GP Holdings, L.P. (PAGP)
| Market Cap | 5.40B +41.3% |
| Revenue (ttm) | 45.26B -9.3% |
| Net Income | 196.00M +35.2% |
| EPS | 0.12 -84.2% |
| Shares Out | 233.00M |
| PE Ratio | 27.57 |
| Forward PE | 12.93 |
| Dividend | $1.67 (7.20%) |
| Ex-Dividend Date | May 1, 2026 |
| Volume | 2,664,494 |
| Open | 23.67 |
| Previous Close | 23.63 |
| Day's Range | 22.99 - 23.67 |
| 52-Week Range | 16.69 - 24.76 |
| Beta | 0.43 |
| Analysts | Buy |
| Price Target | 22.11 (-4.66%) |
| Earnings Date | May 8, 2026 |
About PAGP
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates through Crude Oil and Natural Gas Liquids (NGLs) segments. The company engages in the gathering and transporting crude oil using pipelines, trucks, and barges or railcars. It also provides terminalling, storage, and other related services. In addition, the company is involved in the natural gas processing and NGL fractionation, storage, transportation, and terminall... [Read more]
Financial Performance
In 2025, Plains GP Holdings's revenue was $44.26 billion, a decrease of -9.46% compared to the previous year's $48.89 billion. Earnings were $260.00 million, an increase of 152.43%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for PAGP stock is "Buy." The 12-month stock price target is $22.11, which is a decrease of -4.66% from the latest price.
News
Plains GP Holdings Earnings Call Transcript: Q1 2026
First quarter 2026 Adjusted EBITDA reached $730 million, with strong crude and NGL segment results. Full-year EBITDA guidance was raised by $130 million to $2.88 billion, driven by NGL outperformance, optimization, and the Cactus III acquisition.
Plains All American Pipeline and Plains GP Holdings Provide Update on the NGL Sale Process
HOUSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, “Plains”) today provided an update on the expected timin...
Plains GP Holdings price target raised to $21 from $18 at Barclays
Barclays raised the firm’s price target on Plains GP Holdings (PAGP) to $21 from $18 and keeps an Underweight rating on the shares. The firm says expectations for structurally higher
Plains GP Holdings files to sell Class A shares representing limited partners
No amount was given.
Plains All American, Plains GP give update on Canadian NGL business divestiture
Plains All American (PAA) and Plains GP Holdings (PAGP) provided an update on the expected timing for completion of the Canadian NGL business divestiture to Keyera Corp. The transaction continues
Plains All American Pipeline and Plains GP Holdings Provide Updated Timing for Completion of Sale of NGL Business
HOUSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, "Plains") today provided an update on the expected tim...
Plains GP Holdings initiated with a Buy at Truist
Truist initiated coverage of Plains GP Holdings (PAGP) with a Buy rating and $23 price target Plains is among the largest transporters and gatherers of crude and the “preeminent” crude
Plains GP Holdings price target raised to $24 from $22 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Plains GP Holdings (PAGP) to $24 from $22 and keeps an Equal Weight rating on the shares. The firm updated estimates as
Plains GP Holdings price target raised to $25 from $23 at Stifel
Stifel raised the firm’s price target on Plains GP Holdings (PAGP) to $25 from $23 and keeps a Buy rating on the shares. The firm, which is updating estimates post
Plains GP Holdings price target raised to $20 from $17 at Citi
Citi raised the firm’s price target on Plains GP Holdings (PAGP) to $20 from $17 and keeps a Neutral rating on the shares. The firm upped estimates post the Q4
Plains GP Holdings price target raised to $18 from $17 at Barclays
Barclays analyst Theresa Chen raised the firm’s price target on Plains GP Holdings (PAGP) to $18 from $17 and keeps an Underweight rating on the shares.
Plains GP Holdings Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 adjusted EBITDA reached $738M and $2.83B, respectively, as the company transitioned to a pure-play crude business, divested its NGL segment, and acquired the Cactus 3 pipeline. 2026 guidance calls for $2.75B EBITDA, flat Permian volumes, and continued cost savings.
Plains All American, GP downgraded to Underperform at BofA after outperformance
As previously reported, BofA downgraded Plains All American (PAA) and Plains GP Holdings (PAGP) to Underperform from Neutral with unchanged price targets of $19 each. Plains All American has been
Plains GP Holdings downgraded to Underperform from Neutral at BofA
BofA downgraded Plains GP Holdings (PAGP) to Underperform from Neutral with a $19 price target
Plains GP Holdings price target raised to $23 from $22 at Mizuho
Mizuho raised the firm’s price target on Plains GP Holdings (PAGP) to $23 from $22 and keeps an Outperform rating on the shares. The firm cites the company’s shift toward
Plains GP Holdings price target raised to $22 from $20 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Plains GP Holdings (PAGP) to $22 from $20 and keeps an Equal Weight rating on the shares. AI scrutiny has influenced recent
Plains GP Holdings Earnings Call Transcript: Q3 2025
Q3 2025 adjusted EBITDA reached $669 million, driven by higher crude volumes and recent acquisitions. The Epic Crude Pipeline acquisition and pending NGL asset sale will further focus the business on crude, with leverage expected to normalize post-divestiture.
Plains GP Holdings price target lowered to $22 from $24 at Raymond James
Raymond James analyst Justin Jenkins lowered the firm’s price target on Plains GP Holdings (PAGP) to $22 from $24 and keeps a Strong Buy rating on the shares. The firm
Plains GP Holdings price target lowered to $17 from $18 at Barclays
Barclays analyst Theresa Chen lowered the firm’s price target on Plains GP Holdings (PAGP) to $17 from $18 and keeps an Underweight rating on the shares as part of a
Plains GP Holdings price target lowered to $20 from $21 at JPMorgan
JPMorgan analyst Jeremy Tonet lowered the firm’s price target on Plains GP Holdings (PAGP) to $20 from $21 and keeps a Neutral rating on the shares. The firm updated the
Plains to buy 55% interest in EPIC Crude Holdings, transaction valued at $1.57B
Plains All American Pipeline (PAA) and Plains GP Holdings (PAGP) announced earlier that a wholly owned subsidiary has entered into a definitive agreement to acquire from subsidiaries of Diamondback En...
Plains to buy stake in EPIC Crude in $1.6 billion oil pipeline deal
Plains All American Pipeline and Plains GP Holdings on Tuesday said it has agreed to buy a 55% stake in pipeline operator EPIC Crude Holdings from units of Diamondback Energy and Kinetik Holdings for ...
Plains to acquire 55% interest in EPIC crude holdings
Plains All American Pipeline (PAA) and Plains GP Holdings (PAGP) announced that a wholly owned subsidiary has entered into a definitive agreement to acquire from subsidiaries of Diamondback Energy and
Plains GP Holdings Earnings Call Transcript: Q2 2025
Q2 2025 saw strong adjusted EBITDA and robust crude oil segment results, with the NGL business sale set to streamline operations and boost financial flexibility. Full-year EBITDA guidance remains at $2.8–$2.95 billion, with capital redeployment focused on bolt-on growth and returns.
Plains GP Holdings Earnings Call Transcript: Q1 2025
First-quarter adjusted EBITDA reached $754 million, with strong NGL and crude segment performance despite market volatility. Guidance for 2025 remains unchanged, and the company continues to focus on efficient growth, bolt-on acquisitions, and disciplined capital allocation.